Asset Details
Do you wish to reserve the book?
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
Do you wish to request the book?
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
2012
Overview
Sustaining a high growth rate requires tumors to exploit resources in their microenvironment. One example of this is the extensive angiogenesis that is a typical feature of high-grade gliomas. Here, we show that expression of the constitutively active mutant epidermal growth factor receptor, ΔEGFR (EGFRvIII, EGFR*, de2-7EGFR) is associated with significantly higher expression levels of the pro-angiogenic factor interleukin (IL)-8 in human glioma specimens and glioma stem cells. Furthermore, the ectopic expression of ΔEGFR in different glioma cell lines caused up to 60-fold increases in the secretion of IL-8. Xenografts of these cells exhibit increased neovascularization, which is not elicited by cells overexpressing wild-type (wt)EGFR or ΔEGFR with an additional kinase domain mutation. Analysis of the regulation of IL-8 by site-directed mutagenesis of its promoter showed that ΔEGFR regulates its expression through the transcription factors nuclear factor (NF)-κB, activator protein 1 (AP-1) and CCAAT/enhancer binding protein (C/EBP). Glioma cells overexpressing ΔEGFR showed constitutive activation and DNA binding of NF-κB, overexpression of c-Jun and activation of its upstream kinase c-Jun N-terminal kinase (JNK) and overexpression of C/EBPβ. Selective pharmacological or genetic targeting of the NF-κB or AP-1 pathways efficiently blocked promoter activity and secretion of IL-8. Moreover, RNA interference-mediated knock-down of either IL-8 or the NF-κB subunit p65, in ΔEGFR-expressing cells attenuated their ability to form tumors and to induce angiogenesis when injected subcutaneously into nude mice. On the contrary, the overexpression of IL-8 in glioma cells lacking ΔEGFR potently enhanced their tumorigenicity and produced highly vascularized tumors, suggesting the importance of this cytokine and its transcription regulators in promoting glioma angiogenesis and tumor growth.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ Analysis
/ Animals
/ CCAAT-Enhancer-Binding Proteins - metabolism
/ CCAAT/enhancer-binding protein
/ DNA
/ Epidermal growth factor receptors
/ Female
/ Gene Expression Regulation, Neoplastic
/ Glioma
/ Gliomas
/ Human Umbilical Vein Endothelial Cells - physiology
/ Humans
/ JNK Mitogen-Activated Protein Kinases - antagonists & inhibitors
/ JNK Mitogen-Activated Protein Kinases - metabolism
/ Kinases
/ Medicine
/ Mice
/ Mutation
/ Neoplastic Stem Cells - metabolism
/ Neovascularization, Pathologic - metabolism
/ NF-kappa B - antagonists & inhibitors
/ Oncology
/ Phosphatidylinositol 3-Kinases - metabolism
/ Protein Kinase Inhibitors - pharmacology
/ Protein Processing, Post-Translational
/ Receptor, Epidermal Growth Factor
/ RNA
/ Transcription Factor AP-1 - metabolism
/ Tumors
